| Mar 3, 2025 |
Mar 4, 2025 |
Akebia Therapeutics, Inc.
|
SVP, Chief Medical Officer |
Sell |
51.3
|
-7,144
|
-0.88%
|
✓
|
$13.1K |
| Jan 31, 2025 |
Feb 4, 2025 |
Akebia Therapeutics, Inc.
|
SVP, Chief Medical Officer |
Sell |
95.0
|
+144,394
|
21.49%
|
✓
|
$106.1K |
| Aug 25, 2023 |
May 9, 2024 |
Akebia Therapeutics, Inc.
|
SVP, Chief Medical Officer |
Sell |
26.3
|
-27,000
|
-3.88%
|
✗
|
$31.1K |
| Feb 29, 2024 |
Mar 1, 2024 |
Akebia Therapeutics, Inc.
|
SVP, Chief Medical Officer |
Sell |
46.3
|
-7,169
|
-1.02%
|
✗
|
$11.3K |
| Feb 27, 2024 |
Feb 29, 2024 |
Akebia Therapeutics, Inc.
|
SVP, Chief Medical Officer |
Sell |
48.8
|
-8,367
|
-1.18%
|
✓
|
$12.7K |
| Jan 31, 2024 |
Feb 2, 2024 |
Akebia Therapeutics, Inc.
|
SVP, Chief Medical Officer |
Sell |
91.3
|
+177,889
|
33.34%
|
✗
|
$40.8K |
| May 16, 2023 |
May 18, 2023 |
Akebia Therapeutics, Inc.
|
SVP, Chief Medical Officer |
Sell |
42.5
|
-63,567
|
-10.70%
|
✗
|
$67.9K |
| Mar 1, 2023 |
Mar 3, 2023 |
Akebia Therapeutics, Inc.
|
SVP, Chief Medical Officer |
Sell |
46.3
|
-14,123
|
-2.32%
|
✗
|
$12.4K |
| Feb 27, 2023 |
Mar 1, 2023 |
Akebia Therapeutics, Inc.
|
SVP, Chief Medical Officer |
Sell |
47.5
|
-7,539
|
-1.22%
|
✗
|
$6.1K |
| Aug 31, 2022 |
Sep 1, 2022 |
Akebia Therapeutics, Inc.
|
SVP, Chief Medical Officer |
Sell |
52.5
|
-1,147
|
-0.27%
|
✗
|
$415.8 |
| Feb 28, 2022 |
Mar 2, 2022 |
Akebia Therapeutics, Inc.
|
SVP, Chief Medical Officer |
Sell |
86.3
|
+44,944
|
5.78%
|
✗
|
$32.6K |
| Aug 31, 2021 |
Sep 2, 2021 |
Akebia Therapeutics, Inc.
|
SVP, Chief Medical Officer |
Sell |
50.0
|
-1,042
|
-0.60%
|
✗
|
$2.9K |
| Apr 1, 2021 |
Apr 1, 2021 |
Akebia Therapeutics, Inc.
|
SVP, Chief Medical Officer |
Sell |
50.0
|
-1,081
|
-0.63%
|
✗
|
$3.7K |
| Feb 26, 2021 |
Mar 2, 2021 |
Akebia Therapeutics, Inc.
|
SVP, Chief Medical Officer |
Sell |
91.3
|
+62,442
|
63.07%
|
✗
|
$25.7K |
| Nov 20, 2019 |
Nov 22, 2019 |
Akebia Therapeutics, Inc.
|
SVP, Chief Medical Officer |
Buy |
95.0
|
+27,000
|
270.00%
|
✗
|
$96.7K |
| Dec 15, 2017 |
Dec 18, 2017 |
Protara Therapeutics, Inc.
|
SVP and Chief Medical Officer |
Buy |
86.3
|
+8,666
|
7.84%
|
✗
|
$22.6K |